HK1200103A1 - 用於治療陰道感染和致病性陰道生物被膜的組合物和方法 - Google Patents

用於治療陰道感染和致病性陰道生物被膜的組合物和方法

Info

Publication number
HK1200103A1
HK1200103A1 HK15100563.0A HK15100563A HK1200103A1 HK 1200103 A1 HK1200103 A1 HK 1200103A1 HK 15100563 A HK15100563 A HK 15100563A HK 1200103 A1 HK1200103 A1 HK 1200103A1
Authority
HK
Hong Kong
Prior art keywords
vaginal
compositions
methods
biofilms
pathogenic
Prior art date
Application number
HK15100563.0A
Other languages
English (en)
Inventor
Suzanne Gordon
Dawn Flynn
Original Assignee
Toltec Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toltec Pharmaceuticals Llc filed Critical Toltec Pharmaceuticals Llc
Publication of HK1200103A1 publication Critical patent/HK1200103A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15100563.0A 2007-11-30 2015-01-19 用於治療陰道感染和致病性陰道生物被膜的組合物和方法 HK1200103A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99130807P 2007-11-30 2007-11-30

Publications (1)

Publication Number Publication Date
HK1200103A1 true HK1200103A1 (zh) 2015-07-31

Family

ID=40678965

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11104926A HK1150776A1 (zh) 2007-11-30 2011-05-18 用於治療陰道感染和致病性陰道生物被膜的組合物和方法
HK15100563.0A HK1200103A1 (zh) 2007-11-30 2015-01-19 用於治療陰道感染和致病性陰道生物被膜的組合物和方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK11104926A HK1150776A1 (zh) 2007-11-30 2011-05-18 用於治療陰道感染和致病性陰道生物被膜的組合物和方法

Country Status (9)

Country Link
US (3) US8349368B2 (zh)
EP (3) EP2227213B1 (zh)
CN (2) CN103933063A (zh)
CA (2) CA2706709C (zh)
DK (3) DK2684574T3 (zh)
ES (3) ES2394130T3 (zh)
HK (2) HK1150776A1 (zh)
PL (3) PL2529723T3 (zh)
WO (1) WO2009070638A1 (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548121B2 (ja) 2007-05-14 2014-07-16 リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク バイオフィルム中の細菌細胞における生理学的分散応答の誘導
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US9504739B2 (en) * 2011-03-01 2016-11-29 Quorum Innovations, Llc Method of identifying a biologically-active composition from a biofilm
MX347611B (es) 2011-06-19 2017-05-04 Abogen Inc Dispositivos, soluciones y metodos para recoleccion de muestras.
FR2976808B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition filmogene et son utilisation pour le traitement de l'herpes
ITMI20111151A1 (it) * 2011-06-24 2012-12-25 Lo Li Pharma Srl N-acetil cisteina e sua composizione per uso nel trattamento di patologie vaginali.
WO2013042140A2 (en) * 2011-09-23 2013-03-28 Manu Chaudhary Non antibiotic,non peptide compounds for antibiotic efficacy & safety enhancement
JP2015510914A (ja) 2012-03-19 2015-04-13 ドクトア・アウグスト・ボルフ・ゲーエムベーハー・ウント・コンパニー・カー・ゲー−アルツナイミツテル 膣感染症における病原性膣バイオフィルムの予防及び治療のための両性界面活性剤の使用
EP3013368A1 (en) 2013-06-25 2016-05-04 Mission Pharmacal Company Novel formulations for the treatment of vaginal disorders
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
EP3204016B1 (en) 2014-10-06 2021-08-25 Algamed Therapeutics (A.M.T) Ltd. Compositions comprising sulfated polysaccharides and uses thereof
CN105362289B (zh) * 2015-10-24 2018-08-31 惠峪 一种阴道滞留硼酸制剂及其制备方法
EP3435768A4 (en) * 2016-04-01 2019-10-09 Texas State University COMPOSITIONS AND METHODS FOR DISPERSION OF BIOFILMS
US10583116B2 (en) * 2016-08-31 2020-03-10 Virginia Commonwealth University Local delivery of cholesterol-lowering drugs to treat and prevent bacterial vaginosis
US12011469B2 (en) * 2017-05-23 2024-06-18 Vireo Systems, Inc. Parenteral delivery device and methods of use
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
GR1009621B (el) * 2018-07-25 2019-10-23 Ιουλια Κλεωνος Τσετη Συνθεσεις για τοπικη χρηση, που περιεχουν συνδυασμους βορικου οξεος, ελαιου τεϊοδεντρου, πανθενολης και μπισαμπολολης, χρησιμες για την αντιμετωπιση μυκητιασικων λοιμωξεων
WO2022006298A1 (en) * 2020-06-30 2022-01-06 Vireo Systems, Inc. Compositions for controlling odor and itch and methods of and devices for administering same
WO2023201341A2 (en) * 2022-04-15 2023-10-19 Wayne State University Compositions and methods for the treatment of bacterial vaginosis

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107331A (en) * 1976-03-05 1978-08-15 Max Rosenberg Zinc chelating fungicidal composition
FR2437833A1 (fr) * 1978-10-03 1980-04-30 Rosenberg Max Traitement des affections fongiques au moyen d'agents chelatant les ions zinc
DE2946366C2 (de) * 1979-11-16 1983-12-29 Basotherm GmbH, 7950 Biberach Augentropfenflasche
US4551456A (en) * 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
FR2598081B1 (fr) * 1986-04-30 1990-02-02 Chauvin Blache Lab Procede de preparation d'une solution pharmaceutique aqueuse d'un principe actif constitue par un acide organique
RU2058147C1 (ru) * 1991-05-17 1996-04-20 Станислав Викторович Цивинский Способ предотвращения заражения венерическими болезнями
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
US5853767A (en) * 1997-01-02 1998-12-29 Melman; Steven A. Compositions for treating fungal, parasitic and/or bacterial infections, especially infections of organs such as the skin and vagina
US6106854A (en) * 1998-03-25 2000-08-22 Belfer; William A. Disinfectant composition for infectious water and surface contaminations
US6146622A (en) * 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
CA2350245A1 (en) * 1998-11-06 2000-05-18 Universite De Montreal Improved bactericidal and non-bactericidal solutions for removing biofilms
MXPA01012752A (es) * 1999-06-11 2002-07-02 Sankyo Co Composiciones reductoras de tension intraocular para administracion topica.
JP4687837B2 (ja) * 1999-09-29 2011-05-25 ライオン株式会社 眼科用組成物
WO2001097852A1 (fr) * 2000-06-19 2001-12-27 Santen Pharmaceutical Co., Ltd. Agents aseptiques
JP2002212073A (ja) * 2001-01-15 2002-07-31 Shoei:Kk 水性液剤
WO2003018029A1 (en) * 2001-08-24 2003-03-06 Quorex Pharmaceuticals, Inc. Anti-bacterial agents based upon oxoanion binding
GR20010100507A (el) * 2001-11-01 2003-07-16 Μαυρουδη Γεωργιος Αναγνωσταρας Προϊον θεραπειας κολπικων λοιμωξεων
US20050148570A1 (en) * 2001-11-08 2005-07-07 Liren Huang Novel substituted alkane compounds and uses thereof
EP1453913A4 (en) * 2001-11-08 2006-04-05 Antex Pharma Inc SUBSTITUTED ALKANES COMPOUNDS AND USES THEREOF
AU2003224432A1 (en) * 2002-04-08 2003-10-20 Bergamon S.R.L. Composition for the topical treatment of vulvovaginitis and mycoses
CA2502148A1 (en) * 2002-10-16 2005-02-17 Board Of Regents, The University Of Texas System Methods and compositions for increasing the efficacy of biologically-active ingredients
AU2004296178B2 (en) 2003-12-04 2011-03-24 The United States Of America As Represented By The Department Of Veterans Affairs Gallium inhibits biofilm formation
US20050222169A1 (en) * 2004-01-16 2005-10-06 Nawaz Ahmad Compositions and methods of treating infections
GB0501192D0 (en) * 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
CN1872026A (zh) * 2005-05-30 2006-12-06 张东军 阴道用新型药物制剂
US20070207095A1 (en) 2005-12-09 2007-09-06 Research Foundation Of State University Of New York Induction of a physiological dispersion response in bacterial cells in a biofilm
MX2008009605A (es) * 2006-01-30 2008-12-19 Titan Pharmaceuticals Inc Uso del galio para tratar infecciones asociadas con una biopelicula.

Also Published As

Publication number Publication date
EP2684574A1 (en) 2014-01-15
EP2529723B1 (en) 2016-05-11
EP2227213B1 (en) 2012-08-29
CN101951868A (zh) 2011-01-19
US8349368B2 (en) 2013-01-08
US20150110898A1 (en) 2015-04-23
EP2529723A2 (en) 2012-12-05
ES2572580T3 (es) 2016-06-01
HK1150776A1 (zh) 2012-01-13
CA2706709A1 (en) 2009-06-04
PL2684574T3 (pl) 2017-08-31
DK2529723T3 (en) 2016-06-13
DK2684574T3 (en) 2016-08-29
EP2529723A3 (en) 2013-04-03
ES2588437T3 (es) 2016-11-02
PL2227213T3 (pl) 2013-01-31
CA2853152A1 (en) 2009-06-04
US20090181106A1 (en) 2009-07-16
ES2394130T3 (es) 2013-01-22
PL2529723T3 (pl) 2016-09-30
CA2706709C (en) 2015-06-16
DK2227213T3 (da) 2013-01-02
CA2853152C (en) 2017-04-18
US20130101678A1 (en) 2013-04-25
EP2227213A1 (en) 2010-09-15
EP2227213A4 (en) 2011-01-05
CN101951868B (zh) 2014-03-12
WO2009070638A1 (en) 2009-06-04
CN103933063A (zh) 2014-07-23
US8956663B2 (en) 2015-02-17
EP2684574B1 (en) 2016-07-27

Similar Documents

Publication Publication Date Title
HK1200103A1 (zh) 用於治療陰道感染和致病性陰道生物被膜的組合物和方法
HK1250936A1 (zh) 用於治療病毒感染的化合物和方法
EP2120561A4 (en) COMPOSITIONS FOR TREATING BIOFILMS, AND METHODS FOR THEIR USE
EP2043620A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARASITIC INFECTIONS
HK1134679A1 (zh) 用於治療感染的組合物和方法
EP2490530A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS
ZA200906349B (en) Combination medicaments for treating bacterial infections
ZA201005798B (en) Treatment of microbial infections
ZA201105290B (en) Antibiotic compositions for the treatment of gram negative infections
ZA200900140B (en) Methods and compositions for treating biofilms
HK1161886A1 (en) Novel antibacterial agents for the treatment of gram positive infections
EP2316267A4 (en) ANTIBACTERIAL AGENT AND DISINFECTION METHOD
EP2329819A4 (en) PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF SEXUALLY TRANSMITTED INFECTIONS
EP2271328A4 (en) ANTISEPTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS
ZA201202924B (en) Compositions and methods for treating bacterial infections using ceftaroline
ZA201006657B (en) Disinfection composition and process
EP2326340A4 (en) COMPOSITIONS AND METHODS FOR TREATING PNEUMOCOCCAL INFECTIONS
EP2417258A4 (en) BACTERIOPHAGE COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS
PL2134742T3 (pl) Kompozycje immunogenne do leczenia i profilaktyki zakażeń zwierząt
IL208849A0 (en) Compositions for the treatment of vaginal infections with chronic inflammation
AP2829A (en) Disinfection composition and process
EP2328611A4 (en) COMPOSITIONS AND METHODS FOR TREATING S. PNEUMONIA INFECTION
GB0801768D0 (en) Treatment of microbial infections
IL211282A0 (en) Compositions and use thereof for treating s. pneumoniae infection
IL211283A0 (en) Compositions and use thereof for treating s. pneumoniae infection